| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |